Literature DB >> 11106405

Functions of transforming growth factor-beta isoforms in the nervous system. Cues based on localization and experimental in vitro and in vivo evidence.

K Unsicker1, J Strelau.   

Abstract

This review briefly describes the cellular distribution and documented roles of the transforming growth factor (TGF)-beta isoforms TGF-beta2 and -beta3 in the central and peripheral nervous system. TGF-beta2 and -beta3 are coexpressed in developing radial glial and mature astroglial and Schwann cells, as well as in subpopulations of differentiated neurons, most prominently in cortical, hippocampal, and brainstem/spinal cord motor neurons. In vitro studies have suggested a number of potential, physiologically relevant functions for TGF-betas including regulation of astroglial cell proliferation, expression of adhesion molecules, survival promoting roles for neurons in combination with established neurotrophic factors, and differentiative actions on neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106405     DOI: 10.1046/j.1432-1327.2000.01824.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

Review 1.  Atypical antiinflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine-phosphatidylserine receptor interaction.

Authors:  Roberta De Simone; Maria Antonietta Ajmone-Cat; Luisa Minghetti
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

2.  Characterization of TGF-beta1 type II receptor expression in cultured cortical astrocytes.

Authors:  Vivian De Oliveira Sousa; Juliana Carvalho Almeida; Cristiane Monteiro Eller; Flávia Carvalho Alcantara Gomes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

3.  Ventral mesencephalon astrocytes are more efficient than those of other regions in inducing dopaminergic neurons through higher expression level of TGF-beta3.

Authors:  Kairong Li; Bing Xue; Yue Wang; Xuan Wang; Haomin Wang; Xiaomin Wang
Journal:  J Mol Neurosci       Date:  2008-11-04       Impact factor: 3.444

4.  Smad2 protein disruption in the central nervous system leads to aberrant cerebellar development and early postnatal ataxia in mice.

Authors:  Lixiang Wang; Masatoshi Nomura; Yutaka Goto; Kimitaka Tanaka; Ryuichi Sakamoto; Ichiro Abe; Shohei Sakamoto; Atsushi Shibata; Patricio L M Enciso; Masahiro Adachi; Keizo Ohnaka; Hisaya Kawate; Ryoichi Takayanagi
Journal:  J Biol Chem       Date:  2011-04-04       Impact factor: 5.157

5.  Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage.

Authors:  Yuan Zhu; Guo-Yuan Yang; Barbara Ahlemeyer; Li Pang; Xiao-Ming Che; Carsten Culmsee; Susanne Klumpp; Josef Krieglstein
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

6.  Smad3 deficiency reduces neurogenesis in adult mice.

Authors:  Yu Wang; Aviva J Symes
Journal:  J Mol Neurosci       Date:  2010-02-13       Impact factor: 3.444

7.  Expression of transforming growth factor-beta receptors in meningeal fibroblasts of the injured mouse brain.

Authors:  Yukari Komuta; Xichuan Teng; Hiroko Yanagisawa; Kazunori Sango; Koki Kawamura; Hitoshi Kawano
Journal:  Cell Mol Neurobiol       Date:  2009-08-04       Impact factor: 5.046

8.  SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair.

Authors:  Edmund Au; Miranda W Richter; Adele J Vincent; Wolfram Tetzlaff; Ruedi Aebersold; E Helene Sage; A Jane Roskams
Journal:  J Neurosci       Date:  2007-07-04       Impact factor: 6.167

9.  Reconstitution of Schwannian stroma in neuroblastomas using human bone marrow stromal cells.

Authors:  Wenlin Du; Nobumichi Hozumi; Michiie Sakamoto; Jun-ichi Hata; Taketo Yamada
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

10.  Increased transforming growth factor-beta1 in alcohol dependence.

Authors:  Yong-Ku Kim; Boung Chul Lee; Byung Joo Ham; Byung-Hwan Yang; Sungwon Roh; Joonho Choi; Tae-Cheon Kang; Young-Gyu Chai; Ihn-Geun Choi
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.